GLP-1 Market
LLY $1166.51 ▼ -1.4% NVO $38.06 ▼ -1.3% PFE $28.37 ▼ -0.1% VKTX $26.65 ▼ -6.0% KLRA $10.77 ▼ -4.9% GPCR $22.31 ▼ -6.7% RHHBY $53.77 ▼ -0.6%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Olmesartan Medoxomil

Company
Baylor Research Institute
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
4 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

4 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 14, 2026

Find a Clinical Trial Near Me

See recruiting studies for Olmesartan Medoxomil and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02735707

    Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

    Not yet reported UMC Utrecht 20000 participants Est. completion 2028-02 408 sites
    Other conditions: Community-acquired Pneumonia, Influenza, COVID-19
    View official trial listing →
  • Recruiting NCT NCT05498675

    Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study

    Beijing Friendship Hospital 180 participants Est. completion 2027-06-30 1 site
    Other conditions: Sacubitril/Valsartan, Hypertension, Obesity
    View official trial listing →
  • Recruiting NCT NCT07679828

    Polypills Approach for Multiple Cardiovascular Risk Factors

    Not yet reported China Medical University, China 8252 participants Est. completion 2030-03-01 15 sites Stand-alone
    Other conditions: Hypertension, Dyslipidemia, Diabetes
    View official trial listing →
  • Recruiting NCT NCT07810088

    Dalpiciclib Combined With Aromatase Inhibitors and Olmesartan as the First-line Treatment for HR+/HER2- Advanced Breast Cancer

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40 participants Est. completion 2028-12-01 1 site Stand-alone
    Other conditions: HR+ / HER2- Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT00098137

    Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation

    Not yet reported Atrial Fibrillation Network 422 participants Est. completion 2009-05 Stand-alone
    Other conditions: Heart Disease, Arrhythmia, Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00122447

    Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance

    Not yet reported Emory University 84 participants Est. completion 2011-05 2 sites
    Prediabetes Other conditions: Prediabetic State
    View official trial listing →
  • Completed NCT NCT00134160

    OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study

    Not yet reported OSCAR Study 1000 participants Est. completion 2010-05 2 sites
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00139698

    Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension

    Not yet reported Pfizer 410 participants Est. completion 2006-07 32 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00141453

    ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial

    Not yet reported Daiichi Sankyo Co., Ltd. 577 participants Est. completion 2009-01 2 sites Stand-alone
    Chronic kidney diseaseType 2 diabetes Other conditions: Proteinuria
    View official trial listing →
  • Completed NCT NCT00151775

    Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood Pressure

    Not yet reported, Not yet reported Daiichi Sankyo 362 participants Est. completion 2008-09 65 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00151814

    Olmesartan Pediatric Pharmacokinetic (PK) Study

    Not yet reported Daiichi Sankyo 24 participants Est. completion 2008-02 5 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00151827

    Olmesartan Medoxomil in Hypertension and Renal Impairment

    Not yet reported Sankyo Pharma Gmbh 393 participants Est. completion 2005-07 1 site Stand-alone
    Other conditions: Essential Hypertension, Renal Impairment
    View official trial listing →
  • Completed NCT NCT00171015

    VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil

    Not yet reported Novartis 212 participants Est. completion 2005-04 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00185055

    The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy Subjects

    Not yet reported Daiichi Sankyo 20 participants Est. completion 2005-02
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00185068

    An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension

    Not yet reported Daiichi Sankyo 110 participants Est. completion 2004-10 16 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00185094

    A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin

    Not yet reported Daiichi Sankyo 60 participants Est. completion 2005-07 10 sites
    Metabolic syndrome Other conditions: Hypertension, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00185120

    Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker

    Not yet reported Daiichi Sankyo 152 participants Est. completion 2006-09 20 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00185133

    Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension

    Not yet reported Daiichi Sankyo 1900 participants Est. completion 2007-01 139 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00185159

    Olmesartan Medoxomil in Diabetes Mellitus

    Not yet reported Sankyo Pharma Gmbh 4449 participants Est. completion 2009-07 1 site Stand-alone
    Type 2 diabetesCardiovascular disease Other conditions: Kidney Disease
    View official trial listing →
  • Completed NCT NCT00185172

    Olmesartan in Essential Hypertension

    Not yet reported Sankyo Pharma Gmbh 2333 participants Est. completion 2005-06 8 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00185185

    Olmesartan Medoxomil in Atherosclerosis

    Not yet reported Sankyo Pharma Gmbh 165 participants Est. completion 2006-02 1 site Stand-alone
    Cardiovascular disease Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00220220

    Amlodipine as add-on to Olmesartan in Hypertension

    Not yet reported Sankyo Pharma Gmbh 429 participants Est. completion 2007-04 6 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00220233

    Olmesartan as an add-on to Amlodipine in Hypertension

    Not yet reported Sankyo Pharma Gmbh 632 participants Est. completion 2007-08 5 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00295542

    Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy

    Not yet reported University of Vigo 3344 participants Est. completion 2009-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00311155

    Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension

    Not yet reported Sankyo Pharma Gmbh 694 participants Est. completion 2008-04 79 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00362115

    Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension

    Not yet reported Takeda 449 participants Est. completion 2006-12 54 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00362960

    Olmesartan Medoxomil and Diabetic Nephropathy

    Not yet reported Sankyo Pharma Gmbh 300 participants Est. completion 2004-09 27 sites
    Type 2 diabetesChronic kidney disease Other conditions: Proteinuria, Renal Disease
    View official trial listing →
  • Completed NCT NCT00382213

    A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis

    Not yet reported Daiichi Sankyo 210 participants Est. completion 2004-12
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00403481

    An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes

    Not yet reported Daiichi Sankyo 192 participants Est. completion 2007-12 27 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00412932

    An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With Hypertension

    Not yet reported Daiichi Sankyo 178 participants Est. completion 2008-04 29 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00417222

    Supplemental Benefit of Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan

    Not yet reported Tohoku University 1145 participants Est. completion 2013-12 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT00430508

    Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension

    Not yet reported Daiichi Sankyo 972 participants Est. completion 2008-05 55 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00430638

    A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension

    Not yet reported Daiichi Sankyo 278 participants Est. completion 2007-10 29 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00430950

    Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension

    Not yet reported Daiichi Sankyo 1011 participants Est. completion 2008-10 41 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00441350

    Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension

    Not yet reported Menarini Group 1004 participants Est. completion 2008-05 65 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00454662

    Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)

    Not yet reported COLM Study Research Organization 5141 participants Est. completion 2011-09 1 site
    Cardiovascular disease Other conditions: Hypertension, Diabetes
    View official trial listing →
  • Completed NCT NCT00523744

    Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension

    Not yet reported Novartis 257 participants Est. completion 2007-12 2 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00527514

    Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension

    Not yet reported Daiichi Sankyo 185 participants Est. completion 2008-04 18 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00607035

    The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)

    Not yet reported Jichi Medical University 220 participants Est. completion 2008-05 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00648219

    Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg

    Not yet reported Mylan Pharmaceuticals Inc 36 participants Est. completion 2006-01 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00649389

    Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension

    Not yet reported Daiichi Sankyo 2500 participants Est. completion 2009-12 232 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00649623

    Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg

    Not yet reported Mylan Pharmaceuticals Inc 36 participants Est. completion 2005-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00654745

    18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

    Not yet reported Daiichi Sankyo 207 participants Est. completion 2009-06 21 sites Stand-alone
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00670787

    Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial

    Not yet reported Kyushu University 207 participants Est. completion 2011-02 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00676845

    Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Arterial Protection

    Not yet reported Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 133 participants Est. completion 2011-05 3 sites Stand-alone
    Metabolic syndrome Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00679484

    Study to Demonstrate the Non-inferiority of Olmesartan Medoxomil Versus Candesartan Cilexetil in Reducing Blood B-type (or Brain) Natriuretic Peptide Levels at Week 24

    Not yet reported Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 400 participants Est. completion 2009-11 11 sites Stand-alone
    Heart failure Other conditions: High Blood B-type (or Brain) Natriuretic Peptide (BNP) Level
    View official trial listing →
  • Completed NCT NCT00684489

    Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension

    Not yet reported Medical University of South Carolina 52 participants Est. completion 2005-09
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00696241

    Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension

    Not yet reported Takeda 1275 participants Est. completion 2008-10 85 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00696436

    An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.

    Not yet reported Takeda 1291 participants Est. completion 2009-08 131 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00741585

    Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment

    Not yet reported University of Vigo 21983 participants Est. completion 2018-06-30 20 sites
    Cardiovascular diseaseChronic kidney disease Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00751751

    Olmesartan Medoxomil Versus Losartan in Elderly and Very Elderly

    Not yet reported Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 441 participants Est. completion 2005-06 1 site Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00751829

    Isolated Systolic Hypertension in the Elderly and Very Elderly

    Not yet reported Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 417 participants Est. completion 2005-02 1 site Stand-alone
    Other conditions: Isolated Systolic Hypertension
    View official trial listing →
  • Completed NCT NCT00759551

    Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension

    Not yet reported Takeda 555 participants Est. completion 2005-06 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00772499

    Vascular Improvement With Olmesartan Medoxomil Study

    Not yet reported Daiichi Sankyo 100 participants Est. completion 2005-07 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00791258

    A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure

    Not yet reported Daiichi Sankyo 999 participants Est. completion 2009-09 72 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00796159

    Post-Marketing Surveillance Of Olmesartan Medoxomil In Combination With Hydrochlorothiazide

    Pfizer 1723 participants Est. completion 2008-12
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00811226

    Assessment of the Effectiveness of OLMETEC® and OLMETEC PLUS® for Treatment of Hypertension in Stage I and II Patients (Study P05254)(COMPLETED)

    Schering-Plough 450 participants Est. completion 2008-01
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00834600

    Renin Profiling in Selection of Initial Antihypertensive Drug

    Not yet reported The Louis & Rachel Rudin Foundation 185 participants Est. completion 2011-10 5 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00846365

    Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension

    Not yet reported Takeda 1085 participants Est. completion 2010-06 80 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Status unknown NCT NCT00854763

    Olmesartan on Ambulatory Blood Pressure Change

    National Taiwan University Hospital 100 participants 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00856271

    Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension

    Not yet reported Daiichi Sankyo 287 participants Est. completion 2005-04 5 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00857285

    Olmesartan Medoxomil Versus Losartan in Patients With Hypertension

    Not yet reported Daiichi Sankyo 130 participants Est. completion 2003-09 3 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00858702

    Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension

    Not yet reported Daiichi Sankyo Co., Ltd. 105 participants Est. completion 2005-11 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00872586

    Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension

    Not yet reported Daiichi Sankyo 304 participants Est. completion 2007-08 8 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00890591

    Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension

    Not yet reported Daiichi Sankyo 144 participants Est. completion 2007-08 Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00891267

    Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome

    Not yet reported Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 60 participants Est. completion 2011-05 1 site Stand-alone
    Metabolic syndrome Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00902538

    Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension

    Not yet reported Daiichi Sankyo 2204 participants Est. completion 2010-10 117 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00914524

    Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy

    Not yet reported Daiichi Sankyo Co., Ltd. 49 participants Est. completion 2006-10 1 site Stand-alone
    Chronic kidney disease Other conditions: Chronic Glomerulonephritis
    View official trial listing →
  • Completed NCT NCT00923091

    Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension

    Not yet reported Daiichi Sankyo 2689 participants Est. completion 2011-03 133 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00949884

    Olmesartan Comparison to Losartan in Hypertensive Subjects

    Not yet reported Daiichi Sankyo 941 participants Est. completion 2010-01 20 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00996281

    Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension

    Not yet reported Takeda 837 participants Est. completion 2011-11 26 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01019590

    Fed Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg

    Not yet reported Mylan Pharmaceuticals Inc 36 participants Est. completion 2006-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01020214

    Fasting Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg

    Not yet reported Mylan Pharmaceuticals Inc 36 participants Est. completion 2006-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01028534

    Effects of Antihypertensive Drugs in Patients With Hypertension and Obstructive Sleep Apnea (OSA)

    Not yet reported Kyoto University, Graduate School of Medicine 150 participants Est. completion 2013-12 2 sites
    Obstructive sleep apnea Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01033071

    Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.

    Not yet reported Takeda 1071 participants Est. completion 2010-11 94 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01053026

    Evaluation of Effects of Exercise Training and ARB in DM Patients

    National Taiwan University Hospital 15 participants Est. completion 2011-12 1 site
    Other conditions: Vascular Function, Exercise Training
    View official trial listing →
  • Completed NCT NCT01083017

    Resistant Arterial Hypertension Cohort Study

    University Hospital, Geneva 74 participants Est. completion 2017-05 3 sites
    Other conditions: Hypertension, Essential Hypertension, Resistant Hypertension
    View official trial listing →
  • Withdrawn NCT NCT01089452

    Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure Study

    Not yet reported Monash University 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01101009

    Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure

    Not yet reported Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 486 participants Est. completion 2012-12 15 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01113047

    Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine

    Not yet reported Novartis 347 participants 1 site Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Terminated NCT NCT01132768

    The Confirmatory Olmesartan Plaque Regression Study

    Not yet reported Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 114 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: Essential Hypertension, Carotid Plaque
    View official trial listing →
  • Status unknown NCT NCT01180205

    Telmisartan, Amlodipine and Flow Mediated Dilation

    Not yet reported Johannes Gutenberg University Mainz 576 participants Est. completion 2011-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01198496

    Recurrent Stroke Prevention Clinical Outcome Study

    Not yet reported Biomedis International Ltd. 5000 participants Est. completion 2019-12 1 site
    Cardiovascular disease Other conditions: Hypertension, Blood Pressure
    View official trial listing →
  • Terminated NCT NCT01200407

    Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino Patients

    Pfizer 615 participants Est. completion 2014-01-04 51 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01219556

    Xirtam H Combination In the Treatment of Hypertension Evaluation Study.

    Bayer 8704 participants Est. completion 2013-02 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01271374

    Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome

    Not yet reported InVasc Therapeutics, Inc. 80 participants Est. completion 2011-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01309828

    Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease

    Not yet reported Takeda 153 participants Est. completion 2012-10 53 sites
    Other conditions: Safety
    View official trial listing →
  • Status unknown NCT NCT01377285

    Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)

    Not yet reported National Taiwan University Hospital 350 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Chronic Renal Failure
    View official trial listing →
  • Completed NCT NCT01415466

    Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male Volunteers

    Not yet reported Daewoong Pharmaceutical Co. LTD. 36 participants Est. completion 2011-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01493856

    A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276

    Not yet reported Daewoong Pharmaceutical Co. LTD. 58 participants Est. completion 2012-03 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01552954

    Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With Olmesartan

    Not yet reported Seoul National University Bundang Hospital 269 participants Est. completion 2013-10 7 sites
    Chronic kidney disease Other conditions: Hypertension, Microalbuminuria
    View official trial listing →
  • Completed NCT NCT01599104

    Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension

    Not yet reported Novartis Pharmaceuticals 1161 participants Est. completion 2013-04 61 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01611077

    Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg

    Not yet reported Institut für Pharmakologie und Präventive Medizin 88 participants Est. completion 2013-01 11 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01613209

    Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ Amlodipine

    Not yet reported Institut für Pharmakologie und Präventive Medizin 83 participants Est. completion 2012-10 12 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01615198

    Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension

    Not yet reported Novartis Pharmaceuticals 588 participants Est. completion 2013-07 79 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01684748

    Angiotensin II Blockade and Inflammation in Obesity

    Not yet reported Virginia Polytechnic Institute and State University 20 participants Est. completion 2011-08 Stand-alone
    Other conditions: Overweight, Obese, Prehypertension, Hypertension
    View official trial listing →
  • Completed NCT NCT01692301

    Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension

    Not yet reported Novartis Pharmaceuticals 454 participants Est. completion 2015-04 47 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01715584

    Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 80 participants Est. completion 2019-12-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01764295

    Clinical Study for Patients With Hypertension Associated With Dyslipidemia

    Not yet reported Daewoong Pharmaceutical Co. LTD. 150 participants Est. completion 2013-07 1 site
    Other conditions: Hypertension, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01785472

    Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension

    Not yet reported Novartis Pharmaceuticals 1438 participants Est. completion 2014-08 50 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01823900

    Safety and Pharmacokinetic Comparison of Co-administration and a Combination Drug of Rosuvastatin and Olmesartan in Healthy Male Volunteers

    Not yet reported Severance Hospital 58 participants Est. completion 2012-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01831479

    Investigation of Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan in Healthy Male Volunteers

    Not yet reported Severance Hospital 36 participants Est. completion 2011-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01838850

    Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy

    Not yet reported Daiichi Sankyo Korea Co., Ltd., a Daiichi Sankyo Company 344 participants Est. completion 2014-08 39 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01870739

    A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension

    Not yet reported Novartis Pharmaceuticals 115 participants Est. completion 2015-06 4 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01876368

    Efficacy and Safety of LCZ696 Compared to Olmesartan in Essential Hypertensive Patients Not Responsive to Olmesartan

    Not yet reported Novartis Pharmaceuticals 376 participants Est. completion 2014-08 51 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01907373

    Drug Interaction Study of Olmesartan in Healthy Chinese Volunteers

    Not yet reported Central South University 12 participants Est. completion 2009-10 1 site Stand-alone
    Other conditions: Drug Interaction of Olmesartan in Healthy Chinese Volunteers
    View official trial listing →
  • Status unknown NCT NCT01992796

    Angiotensin II Antagonist in Severe Sepsis

    Not yet reported University of Salerno 300 participants Est. completion 2017-01 1 site
    Other conditions: Severe Sepsis
    View official trial listing →
  • Status unknown NCT NCT02058472

    Pharmacokinetic/Pharmacodynamic & Safety Study of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers

    Not yet reported Dong-A Pharmaceutical Co., Ltd. 30 participants Est. completion 2014-05 Stand-alone
    Other conditions: Healthy Adult Volunteers
    View official trial listing →
  • Completed NCT NCT02089399

    Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers

    Not yet reported Daewoong Pharmaceutical Co. LTD. 32 participants Est. completion 2014-06 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02128386

    Medication Adherence and "True" Resistance in Patients With Resistant Hypertension

    Charite University, Berlin, Germany 50 participants Est. completion 2016-03 1 site
    Other conditions: Hypertensive Disease, Hypertension, Resistant to Conventional Therapy
    View official trial listing →
  • Completed NCT NCT02360644

    Drug Metabolizing Enzyme and Transporter Function in Chronic Kidney Disease

    Not yet reported University of Colorado, Denver 23 participants Est. completion 2019-02-01 2 sites Stand-alone
    Chronic kidney disease Other conditions: Deficiency, Vitamin D
    View official trial listing →
  • Status unknown NCT NCT02360956

    Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)

    Not yet reported Chinese PLA General Hospital 100 participants Est. completion 2016-06 1 site Stand-alone
    Other conditions: Coronary Atherosclerosis
    View official trial listing →
  • Terminated NCT NCT02373462

    Effect of olmesaRtan on Walking distancE and quaLIty of lifE in Peripheral Artery Disease Patients With Hypertension Treated For Intermittent Claudication (RELIEF)

    Not yet reported Yonsei University 1 participants Est. completion 2015-11-17 1 site Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT02377661

    Lowering Blood Pressure in Primary Care in Vienna

    Not yet reported Wilhelminenspital Vienna 229 participants Est. completion 2017-05-30 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT02407210

    Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 304 participants 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT02449811

    RAS Peptide Profiles in Patients With Arterial Hypertension

    Insel Gruppe AG, University Hospital Bern 107 participants Est. completion 2018-11 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Withdrawn NCT NCT02483936

    Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension Control

    Not yet reported EMS Stand-alone
    Other conditions: Arterial Hypertension
    View official trial listing →
  • Withdrawn NCT NCT02493322

    Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control

    Not yet reported EMS Stand-alone
    Other conditions: Essential Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT02495324

    Fimasartan Achieving SBP Target (FAST) Study

    Not yet reported Boryung Pharmaceutical Co., Ltd 369 participants Est. completion 2017-05 8 sites
    Other conditions: Essential,Hypertension
    View official trial listing →
  • Status unknown NCT NCT02516826

    The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease

    Not yet reported Samsung Medical Center 504 participants Est. completion 2018-08 1 site Stand-alone
    Other conditions: Coronary Syndrome
    View official trial listing →
  • Status unknown NCT NCT02561884

    A Single-dose, Randomized, Two-period, Two-treatment, Two-sequence, Crossover Bioequivalence Study on a Olostar Tab Versus Two Co-administered Reference Products Olmesartan Medoxomil and Rosuvastatin Calcium in Healthy Volunteers

    Not yet reported Daewoong Pharmaceutical Co. LTD. 58 participants Est. completion 2015-10
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02609490

    Azilsartan in Chinese Patients With Mild and Moderate Hypertension

    Not yet reported Lee's Pharmaceutical Limited 304 participants Est. completion 2018-08 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT02665832

    Study of DWJ1351 in Healthy Male Volunteers

    Not yet reported Daewoong Pharmaceutical Co. LTD. 58 participants Est. completion 2016-06 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02848170

    Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension

    Not yet reported Daiichi Sankyo Co., Ltd. 40 participants Est. completion 2017-04 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT02962258

    BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions

    Not yet reported Torrent Pharmaceuticals Limited 34 participants Est. completion 2011-06
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT02962336

    Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions.

    Not yet reported Torrent Pharmaceuticals Limited 34 participants Est. completion 2011-06 Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT02996916

    Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose Tissue

    Not yet reported Kurume University 100 participants Est. completion 2020-12 1 site
    Other conditions: Efficacy of Olmesartan on Cerebral Glucose Metabolism in Essential Hypertension
    View official trial listing →
  • Completed NCT NCT03009487

    A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia

    Not yet reported Daewoong Pharmaceutical Co. LTD. 265 participants Est. completion 2018-04 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemias
    View official trial listing →
  • Status unknown NCT NCT03015311

    Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients

    Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 8000 participants Est. completion 2021-12-31 42 sites Stand-alone
    Other conditions: Primary Hypertension
    View official trial listing →
  • Completed NCT NCT03024476

    Optimization of Blood Pressure Management After Acute Ischemic Stroke and Its Prognostic Significance

    Not yet reported Seoul National University Bundang Hospital 67 participants Est. completion 2017-12-07 3 sites Stand-alone
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03318354

    Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablet Under Fasting Conditions

    Not yet reported Torrent Pharmaceuticals Limited 34 participants Est. completion 2010-07 Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT03319706

    Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablets Under Fed Conditions

    Not yet reported Torrent Pharmaceuticals Limited 34 participants Est. completion 2010-09 Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT03560804

    Use of Impedance Cardiography and Applanation Tonometry for Prediction of the Antihypertensive Effect of Two Drugs

    Not yet reported AHEPA University Hospital 60 participants Est. completion 2017-09-15 1 site
    Other conditions: Arterial Stiffness, Ambulatory Blood Pressure Monitoring
    View official trial listing →
  • Completed NCT NCT03655964

    Effect of Olmesartan and Nebivolol on Ambulatory Blood Pressure and Arterial Stiffness in Acute Stage of Ischemic Stroke

    Not yet reported Aristotle University Of Thessaloniki 60 participants Est. completion 2019-08-20 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03753477

    Clinical Trial to Investigate the Efficacy and Safety of DWJ1351

    Not yet reported Daewoong Pharmaceutical Co. LTD. 64 participants Est. completion 2018-02-01 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03951051

    The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting Conditions.

    Not yet reported Pharmtechnology LLC 32 participants Est. completion 2019-06-16 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT04061824

    Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia

    Not yet reported Yonsei University 150 participants Est. completion 2018-12-20 1 site Stand-alone
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT04120753

    Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab

    Not yet reported Daewoong Pharmaceutical Co. LTD. 106 participants Est. completion 2021-07-06 1 site
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT04138888

    A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration Under Fasting Conditions

    Not yet reported Pharmtechnology LLC 32 participants Est. completion 2019-12-24 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Status unknown NCT NCT04161001

    Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451

    Not yet reported Daewoong Pharmaceutical Co. LTD. 237 participants Est. completion 2022-02-02 1 site Stand-alone
    Other conditions: Hypertension, Dyslipidemia
    View official trial listing →
  • Status unknown NCT NCT04174456

    Combination of Olmesartan Effect on Myocardial Viability of Patients With Dilated Cardiomyopathy

    Not yet reported Dong-A University 40 participants Est. completion 2021-12-31 1 site Stand-alone
    Other conditions: Dilated Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT04185857

    MRA and ARB Treatment in Screening of Primary Aldosteronism

    University Hospital Padova 50 participants Est. completion 2019-10-25 1 site
    Other conditions: Primary Aldosteronism Due to Aldosterone Producing Adenoma
    View official trial listing →
  • Suspended NCT NCT04330300

    Coronavirus (COVID-19) ACEi/ARB Investigation

    Not yet reported National University of Ireland, Galway, Ireland 2414 participants Est. completion 2021-12-01 1 site
    Other conditions: Hypertension, COVID-19
    View official trial listing →
  • Completed NCT NCT04394117

    Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease

    Not yet reported The George Institute 787 participants Est. completion 2022-01-17 22 sites
    Other conditions: Coronavirus Disease 2019, COVID-19
    View official trial listing →
  • Completed NCT NCT04467931

    ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

    University of Utah 22213 participants Est. completion 2020-12-31 1 site
    Other conditions: Hypertension, COVID
    View official trial listing →
  • Terminated NCT NCT04606563

    Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?

    Not yet reported University of British Columbia 341 participants Est. completion 2022-04-22 13 sites Stand-alone
    Other conditions: Covid19, SARS-CoV Infection
    View official trial listing →
  • Status unknown NCT NCT04743063

    Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty

    Brigham and Women's Hospital 40000 participants Est. completion 2022-12-31 1 site
    Heart failure Other conditions: Frailty
    View official trial listing →
  • Completed NCT NCT04856969

    Clinical Trial to Evaluate Pharmacokinetic Interaction of ATB-1011 and ATB-1012 in Healthy Adult Volunteers

    Not yet reported Autotelicbio 38 participants Est. completion 2021-05-04 1 site
    Other conditions: Healthy Adult Volunteers
    View official trial listing →
  • Completed NCT NCT05017987

    Clinical Trial to Compare Pharmacokinetics After Administration of ATB-101 or Co-administration of ATB-1011 and ATB-1012

    Not yet reported Autotelicbio 36 participants Est. completion 2021-07-12 1 site
    Other conditions: Healthy Adult Volunteers
    View official trial listing →
  • Status unknown NCT NCT05033535

    s086 Tablets in the Treatment of Mild to Moderate Essential Hypertension

    Not yet reported Shenzhen People's Hospital 10 participants Est. completion 2022-06-30 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT05103332

    Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)

    Not yet reported Alnylam Pharmaceuticals 663 participants Est. completion 2024-09-13 110 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT05110898

    Efficacy and Safety Study of the Fixed-dose Combination of Olmesartan + Indapamide When Compared to the Isolated Drugs in the Treatment of Hypertension.

    Not yet reported Brainfarma Industria Química e Farmacêutica S/A 400 participants Est. completion 2023-10-01 Stand-alone
    Other conditions: Hypertension, Hypertension,Essential
    View official trial listing →
  • Completed NCT NCT05184179

    Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab

    Daewoong Pharmaceutical Co. LTD. 5450 participants Est. completion 2022-08-16 1 site
    Other conditions: Hypertension, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT05189015

    Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and Hypertension

    Not yet reported Seoul National University Bundang Hospital 80 participants Est. completion 2023-06-30 1 site Stand-alone
    Type 2 diabetes Other conditions: Angiotensin/Renin/Aldosterone Hypertension, Hypertension
    View official trial listing →
  • Active, not recruiting NCT NCT05411887

    Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab

    Daewoong Pharmaceutical Co. LTD. 2845 participants Est. completion 2025-12-31 1 site
    Other conditions: Hyperlipidemias, Hypertension
    View official trial listing →
  • Active, not recruiting NCT NCT05660135

    Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia

    Daewoong Pharmaceutical Co. LTD. 4000 participants Est. completion 2025-12-31 1 site
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT05874349

    Histopathologic and Lymphocyte Subpopulations Evaluation of the Upper Gastrointestinal Tract of Crohn's Disease

    Hospital Mutua de Terrassa 200 participants Est. completion 2023-01-01 1 site
    Other conditions: Crohn Disease
    View official trial listing →
  • Status unknown NCT NCT05917275

    Multi-Omics to Predict the Blood Pressure Response to Antihypertensives

    Not yet reported Radboud University Medical Center 96 participants Est. completion 2025-10 1 site Stand-alone
    Other conditions: Primary Hypertension
    View official trial listing →
  • Status unknown NCT NCT06275763

    Optimal Medical Treatment of Difficult-to-treat Hypertension

    Not yet reported National Institute of Cardiology, Warsaw, Poland 2500 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT06515678

    Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension

    Groupe Hospitalier Pitie-Salpetriere 9464 participants Est. completion 2024-08-31 2 sites
    Other conditions: Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab, Hypertension
    View official trial listing →
  • Withdrawn NCT NCT06608472

    Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension

    Not yet reported Eurofarma Laboratorios S.A. Est. completion 2029-10-30 Stand-alone
    Other conditions: Essential Arterial Hypertension
    View official trial listing →
  • Not yet recruiting NCT NCT07262710

    Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 13656 participants Est. completion 2026-08-19
    Cardiovascular disease
    View official trial listing →
  • Enrolling by invitation NCT NCT07547878

    Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

    Not yet reported Baylor Research Institute 64 participants Est. completion 2029-03-31 1 site
    Chronic kidney diseaseType 2 diabetes
    View official trial listing →
  • Not yet recruiting NCT NCT07590466

    A Study to Compare the Pharmacokinetics and Safety of the ATB-U101 and ATB-U1011+ATB-U1012 and ATB-1011+ATB-1012 in Healthy Caucasian Participants

    Not yet reported Autotelicbio 36 participants Est. completion 2026-08-31 Stand-alone
    Other conditions: Diabete Type 2, Hypertension
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Olmesartan Medoxomil, Benicar, Benicar HCT, Olmesartan

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.